Atara Biotherapeutics Inc (NASDAQ: ATRA) stock closed at $11.40 on 12/20/24 after a major increase of 14.8%. Moreover, above average trading volume at 141% of normal accompanied the advance. The stock has risen 4.1% during the last week but has been extremely weak relative to the market over the last nine months.
Current PriceTarget Research Rating
Atara Biotherapeutics is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment